Abbisko Therapeutics Co. Ltd.
- Biotech or pharma, therapeutic R&D
Abbisko Therapeutics (HKEX: 02256.HK), an innovative biopharmaceutical company based in Shanghai, China, is dedicated to the discovery and development of novel and differentiated therapies to address unmet medical needs in China and worldwide. The company was established by a group of seasoned drug hunters with rich R&D and managerial expertise from top multinational pharmaceutical companies. Since its founding in 2016, Abbisko Therapeutics has built an extensive pipeline of 18 innovative programs, 12 of which are currently in clinical stages, focused on areas including precision oncology and immuno-oncology.
We will not be accepting meeting requests from CROs, CDMOs, or any other service vendors at this time.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}